Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Lacklustre start to the week
Mon, 13 Dec 09:30 am

Asian markets have opened this week on a positive note. China and Hong Kong are leading the pack with gains of 1.1% and 0.7% respectively. As for the Indian markets, these have opened on a cautious yet positive note. Metal and auto stocks are leading the gains currently. IT and telecom stocks are however trading with marginal losses.

The BSE-Sensex is trading higher by around 15 points (0.1%), while the NSE-Nifty is down about 5 points (0.1%). Mid and small cap stocks are trading stronger, with the BSE-Midcap and BSE-Smallcap indices up by 1% apiece. The rupee is trading at 45.15 to the US dollar.

Steel stocks have opened strong today. SAIL and Tata Steel are leading the gainers' pack currently. A leading business daily has reported that domestic steel prices are expected to remain on an upswing in the near term. This is given that the cost of key inputs like iron ore, scrap and coking coal are increasing, and companies would need to raise product prices to ward off pressure from their margins. While these input prices are higher as compared to last year, steel prices haven't moved much. In the longer term, with rising demand from infrastructure industries, https://www.equitymaster.com/research-it/sector-info/steel/ . However it is the near term pressure on margins that's keeping the steel companies bothered. There are expectations that companies are looking to raise prices by around Rs 1,500 per tonne starting January 2011.

Domestic pharma stocks are also trading with gains currently. Elder Pharma, Cadila Healthcare, and Biocon are leading the gains. As reported by a leading business daily, Sun Pharma is looking to spend US$ 300 m for acquiring a company in the US, which is by far the largest market for generic companies. The company has already built up a cash war chest of US$ 700 m, a part of which will go towards funding this acquisition. The company has been known for its inorganic growth strategy, given that it has acquired almost 16 companies over the past 14 years of its existence. The latest to come into its fold, and after a long fought battle, was Israel based Taro. Post the acquisition of Taro, the US contributes to more than 50% of Sun Pharma's total sales. While the contribution from India stands at around 30%, 14% comes from other markets like Europe, Russia and South America.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Lacklustre start to the week". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.